Histologic transformation of EGFR mutant non-small cell lung cancer to small cell lung cancer is an important mechanism of resistance to EGFR tyrosine kinase inhibitors that occurs in approximately 3–10% of EGFR mutant non-small cell lung cancers [132]. Here, EGFR is linked to non-small cell lung carcinoma.